12:00 AM
May 14, 2012
 |  BC Week In Review  |  Company News  |  Deals

Aeras, IDRI deal

The not-for-profits partnered to co-develop IDRI's ID93/GLA-SE tuberculosis (TB) vaccine. The partners said they will begin a Phase I trial...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >